A public health collaboration for the surveillance of autism spectrum disorders
- PMID:17302648
- DOI: 10.1111/j.1365-3016.2007.00801.x
A public health collaboration for the surveillance of autism spectrum disorders
Abstract
Autism spectrum disorders (ASDs) represent a range of behavioural phenotypes defined by impaired development in social interaction, communication, imagination, and range of interests or behaviours. The aetiology and epidemiology of these serious developmental disabilities (DDs) are poorly understood. Estimates of the population prevalence of ASDs have varied widely within the US and abroad, with increasing estimates in most of the recent studies. In an effort to improve our understanding of the prevalence, population characteristics and public health impact of these conditions, the Centers for Disease Control and Prevention has funded a multi-site surveillance network for ASDs and other DDs that consists of programmes known as the Autism and Developmental Disabilities Monitoring (ADDM) network which conducts surveillance activities and the Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) which also conducts surveillance in addition to special research studies related to the ASDs. This collaboration will be referred to hereafter as the ADDM Network. The ADDM Network is implementing a multiple-source surveillance programme to determine population prevalence and characteristics of ASDs and other DDs. This paper describes the collaborative efforts and explains the methods in developing this coordinated public health surveillance network to provide an ongoing source of high-quality data on ASDs.
Similar articles
- Evaluation of a methodology for a collaborative multiple source surveillance network for autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002.Van Naarden Braun K, Pettygrove S, Daniels J, Miller L, Nicholas J, Baio J, Schieve L, Kirby RS, Washington A, Brocksen S, Rahbar H, Rice C; Centers for Disease Control and Prevention.Van Naarden Braun K, et al.MMWR Surveill Summ. 2007 Feb 9;56(1):29-40.MMWR Surveill Summ. 2007.PMID:17287716
- Public health monitoring of developmental disabilities with a focus on the autism spectrum disorders.Rice C, Schendel D, Cunniff C, Doernberg N.Rice C, et al.Am J Med Genet C Semin Med Genet. 2004 Feb 15;125C(1):22-7. doi: 10.1002/ajmg.c.30006.Am J Med Genet C Semin Med Genet. 2004.PMID:14755430Review.
- Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, six sites, United States, 2000.Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000 Principal Investigators; Centers for Disease Control and Prevention.Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000 Principal Investigators, et al.MMWR Surveill Summ. 2007 Feb 9;56(1):1-11.MMWR Surveill Summ. 2007.PMID:17287714
- Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention.Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators, et al.MMWR Surveill Summ. 2012 Mar 30;61(3):1-19.MMWR Surveill Summ. 2012.PMID:22456193
- Healthcare for children with autism: the Autism Treatment Network.Coury D, Jones NE, Klatka K, Winklosky B, Perrin JM.Coury D, et al.Curr Opin Pediatr. 2009 Dec;21(6):828-32. doi: 10.1097/MOP.0b013e328331eaaa.Curr Opin Pediatr. 2009.PMID:19745738Review.
Cited by
- Comparison of autism spectrum disorder surveillance status based on two different diagnostic schemes: Findings from the Metropolitan Atlanta Developmental Disabilities Surveillance Program, 2012.Wiggins L, Christensen D, Van Naarden Braun K, Martin L, Baio J.Wiggins L, et al.PLoS One. 2018 Nov 30;13(11):e0208079. doi: 10.1371/journal.pone.0208079. eCollection 2018.PLoS One. 2018.PMID:30500831Free PMC article.
- Finnish Prenatal Study of Autism and Autism Spectrum Disorders (FIPS-A): overview and design.Lampi KM, Banerjee PN, Gissler M, Hinkka-Yli-Salomäki S, Huttunen J, Kulmala U, Lindroos J, Niemelä S, Rihko M, Ristkari T, Saanakorpi K, Sarlin T, Sillanmäki L, McKeague IW, Surcel HM, Helenius H, Brown AS, Sourander A.Lampi KM, et al.J Autism Dev Disord. 2011 Aug;41(8):1090-6. doi: 10.1007/s10803-010-1132-6.J Autism Dev Disord. 2011.PMID:21082229
- Aberrant immune responses in a mouse with behavioral disorders.Heo Y, Zhang Y, Gao D, Miller VM, Lawrence DA.Heo Y, et al.PLoS One. 2011;6(7):e20912. doi: 10.1371/journal.pone.0020912. Epub 2011 Jul 20.PLoS One. 2011.PMID:21799730Free PMC article.
- Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014.Baio J, Wiggins L, Christensen DL, Maenner MJ, Daniels J, Warren Z, Kurzius-Spencer M, Zahorodny W, Robinson Rosenberg C, White T, Durkin MS, Imm P, Nikolaou L, Yeargin-Allsopp M, Lee LC, Harrington R, Lopez M, Fitzgerald RT, Hewitt A, Pettygrove S, Constantino JN, Vehorn A, Shenouda J, Hall-Lande J, Van Naarden Braun K, Dowling NF.Baio J, et al.MMWR Surveill Summ. 2018 Apr 27;67(6):1-23. doi: 10.15585/mmwr.ss6706a1.MMWR Surveill Summ. 2018.PMID:29701730Free PMC article.
- Psychiatric comorbidity and medication use in adults with autism spectrum disorder.Buck TR, Viskochil J, Farley M, Coon H, McMahon WM, Morgan J, Bilder DA.Buck TR, et al.J Autism Dev Disord. 2014 Dec;44(12):3063-71. doi: 10.1007/s10803-014-2170-2.J Autism Dev Disord. 2014.PMID:24958436Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources